These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32987362)
1. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44. Kim SI; Kim YH; Kang BG; Kang MK; Lee EJ; Kim DY; Oh H; Oh SY; Na W; Lim SS; Kang YH Phytomedicine; 2020 Dec; 79():153351. PubMed ID: 32987362 [TBL] [Abstract][Full Text] [Related]
2. Cirsium Setidens Water Extracts Containing Linarin Block Estrogen Deprivation-Induced Bone Loss in Mice. Oh MS; Kim SI; Sim YE; Park SH; Kang MK; Kang IJ; Lim SS; Kang YH Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675135 [TBL] [Abstract][Full Text] [Related]
3. Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking. Na W; Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Kang YH Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203061 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway. Lee EJ; Kim JL; Gong JH; Park SH; Kang YH Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823 [TBL] [Abstract][Full Text] [Related]
5. Fisetin antagonizes cell fusion, cytoskeletal organization and bone resorption in RANKL-differentiated murine macrophages. Kim YH; Kim JL; Lee EJ; Park SH; Han SY; Kang SA; Kang YH J Nutr Biochem; 2014 Mar; 25(3):295-303. PubMed ID: 24524902 [TBL] [Abstract][Full Text] [Related]
6. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway. Li X; Ye JX; Xu MH; Zhao MD; Yuan FL Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470 [TBL] [Abstract][Full Text] [Related]
7. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo. Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187 [TBL] [Abstract][Full Text] [Related]
8. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice. Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277 [TBL] [Abstract][Full Text] [Related]
9. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. Biswas RS; Baker D; Hruska KA; Chellaiah MA BMC Cell Biol; 2004 May; 5():19. PubMed ID: 15142256 [TBL] [Abstract][Full Text] [Related]
10. Vaccaria hypaphorine impairs RANKL-induced osteoclastogenesis by inhibition of ERK, p38, JNK and NF-κB pathway and prevents inflammatory bone loss in mice. Chen H; Guo T; Wang D; Qin R Biomed Pharmacother; 2018 Jan; 97():1155-1163. PubMed ID: 29136954 [TBL] [Abstract][Full Text] [Related]
11. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547 [TBL] [Abstract][Full Text] [Related]
12. Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. Ma T; Sadashivaiah K; Madayiputhiya N; Chellaiah MA J Biol Chem; 2010 Sep; 285(39):29911-24. PubMed ID: 20650888 [TBL] [Abstract][Full Text] [Related]
13. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways. Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759 [TBL] [Abstract][Full Text] [Related]
14. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2. Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796 [TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis. Gupta A; Cao W; Chellaiah MA Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907 [TBL] [Abstract][Full Text] [Related]
16. Safflower bud inhibits RANKL-induced osteoclast differentiation and prevents bone loss in ovariectomized mice. Choi JH; Lim SK; Kim DI; Park MJ; Kim YK; Lee AC; Kim YM; Yang SJ; Park JH Phytomedicine; 2017 Oct; 34():6-13. PubMed ID: 28899511 [TBL] [Abstract][Full Text] [Related]
17. Tablysin-15 inhibits osteoclastogenesis and LPS-induced bone loss via attenuating the integrin α Zeng Q; Lu W; Deng Z; Wu J; Guo R; Xu X Chem Biol Interact; 2020 Aug; 327():109179. PubMed ID: 32534990 [TBL] [Abstract][Full Text] [Related]
18. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Duong LT; Rodan GA Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033 [TBL] [Abstract][Full Text] [Related]